You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1123 Checkpoint inhibitor administered either systemically or subcutaneously enhances the anti-tumor immunity of SD-101 delivered by PEDD device in treating liver metastasis

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1123 Checkpoint inhibitor administered either systemically or subcutaneously enhances the anti-tumor immunity of SD-101 delivered by PEDD device in treating liver metastasis

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023148010
Dec 20239009
Jan 20247102
Feb 20246001
Mar 20246201
Apr 20241401
May 20241201
Jun 20241801
Jul 20242201
Aug 20241402
Sep 20241001
Oct 2024603
Nov 20241204
Dec 2024604
Jan 20251803
Feb 2025001
Mar 2025108
Apr 2025001
May 2025002
Jun 2025003
Total564059